Memantine, an amantadine derivative with some dopaminergic effects, has been proposed as an antiparkinson agent and has may be used to treat moderate to severe Alzheimers disease. It acts on the glutamatergic system by blocking NMDA receptors.
Molekulargewicht:
179.3
Reinheit:
>98% (HPLC)
CAS Nummer:
[19982-08-2]
Formel:
C12H21N
Target-Kategorie:
Endogenous Metabolite
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten